Evidence map›Paper›PMID 28806404›Full record

ArticlePloS one2017

RIG-I and IL-6 are negative-feedback regulators of STING induced by double-stranded DNA.

Xueling Wu, Jun Yang, Tao Na, Kehua Zhang, Andrew M Davidoff, Bao-Zhu Yuan, Youchun Wang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. (-)-α-Bisabolol inhibits D-Gal-induced HSF cellular senescenceIranian journal of basic medical sciences · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Nanoparticle Delivery of RIG-I Agonist Enables Effective and Safe Adjuvant Therapy in Pancreatic Cancer.Molecular therapy : the journal of the American Society of Gene Therapy · 2019
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Xueling WuGraduate School of Peking Union Medical College, Beijing, China.
Jun YangDepartment of Surgery, St Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Tao NaCell Collection and Research Center, National Institutes for Food and Drug Control, Beijing, China.
Kehua ZhangCell Collection and Research Center, National Institutes for Food and Drug Control, Beijing, China.
Andrew M DavidoffDepartment of Surgery, St Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Bao-Zhu YuanCell Collection and Research Center, National Institutes for Food and Drug Control, Beijing, China.
Youchun WangGraduate School of Peking Union Medical College, Beijing, China.ORCID http://orcid.org/0000-0001-9769-5141
National Institutes for Food and Drug Control · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNSt. Jude Children's Research Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The stimulator of interferon genes (STING) protein has emerged as a critical signal transduction molecule in the innate immune response. Sustained activation of the STING signaling induced by cytosolic DNA has been considered to be the cause of a variety of autoimmune diseases characterized by uncontrolled inflammation. Therefore, it is important to understand the molecular basis of the regulation of STING signaling pathway. Here we demonstrate that the STING protein undergoes a proteasome-mediated degradation in human diploid cell (HDC) lines including MRC-5 following the transfection of double-stranded DNA (dsDNA). The degradation of STING is accompanied by the increased expression of both RIG-I and IL-6. Employing the RIG-I siRNA knockdown and an IL-6 neutralizing antibody greatly inhibits the degradation of STING induced by dsDNA. We further demonstrate that both IL-6 and RIG-I are downstream molecules of STING along the DNA sensor pathway. Therefore, STING degradation mediated by RIG-I and IL-6 may serve as a negative feedback mechanism to limit the uncontrolled innate immune response induced by dsDNA. We have further shown that RIG-I and IL-6 promote STING degradation by activating/dephosphorylating UNC-51-like kinase (ULK1). Interestingly, the STING protein is not significantly affected by dsDNA in non-HDC HEK293 cells. Our study thus has identified a novel signaling pathway for regulating STING in HDCs.

Indexed as

Autophagy-Related Protein-1 HomologDEAD Box Protein 58DNAFeedback, PhysiologicalHEK293 CellsHumansInterferon-betaInterleukin-6Intracellular Signaling Peptides and ProteinsMembrane ProteinsPlasmidsProteasome Endopeptidase ComplexProteolysisReceptors, ImmunologicSTING ProteinVirus ReplicationAutophagy-Related Protein-1 HomologDEAD Box Protein 58DNAInterferon-betaInterleukin-6Intracellular Signaling Peptides and ProteinsMembrane ProteinsProteasome Endopeptidase ComplexReceptors, ImmunologicRIGI protein, humanSTING1 protein, humanSTING ProteinULK1 protein, human

Identifiers

PMID28806404
PMCPMC5555650
OpenAlexW2748329964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.